Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Hong Kongby krapalmApril 30, 2025PR Newswire
Appian Embeds Agentic AI into Business Processes to Deliver Scalable, Governable Enterprise Valueby krapalmApril 30, 2025PR Newswire
Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignanciesby krapalmApril 30, 2025PR Newswire
137th Canton Fair Phase 2 Highlights Quality Home Life Through Innovation and Green Thinkingby krapalmApril 30, 2025PR Newswire
Appian Customers Unlock AI’s Full Potential by Embedding It in Business Processesby krapalmApril 30, 2025PR Newswire
【C.S Group】: Launches Antcin A-Based Veterinary Drug Initiative Across Taiwan and Chinaby krapalmApril 30, 2025PR Newswire
Henley & Partners แถลงตอบโต้คำตัดสินของศาลยุติธรรมแห่งสหภาพยุโรปเกี่ยวกับโครงการให้สัญชาติมอลตาby krapalmApril 30, 2025PR Newswire
Nanoprecise เปิดตัว ReKurv.ai ระบบโต้ตอบอัจฉริยะเพื่อการดูแลสินทรัพย์ยุคใหม่by krapalmApril 30, 2025PR Newswire
Nisun International Enterprise Development Group Co., Ltd Reports Full Year 2024 Financial Resultsby krapalmApril 30, 2025PR Newswire
e& achieves AED 16.9 billion consolidated revenue growing 18.7% YoY in Q1 2025by krapalmApril 30, 2025PR Newswire
VOC.AI Secures 15 Million Dollars Funding to Fuel Global Growth and Transform AI-Driven Customer Service Solutionsby krapalmApril 30, 2025PR Newswire
TERREPOWER หรือชื่อเดิม BBB Industries เปิดตัวรายงานความยั่งยืนขององค์กรประจำปี 2567 เพื่อแสดงความก้าวหน้าสู่การเป็นผู้นำเศรษฐกิจหมุนเวียนby krapalmApril 29, 2025PR Newswire
Henley & Partners Responds to European Court of Justice Ruling on Malta’s Citizenship Programby krapalmApril 29, 2025PR Newswire
LoveStudy AI Launches Innovative AI Flashcard Generator Platform for Enhanced Learningby krapalmApril 29, 2025PR Newswire
Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilarby krapalmApril 29, 2025PR Newswire
Henlius Enters into License Agreement with Sandoz for Proposed Ipilimumab Biosimilarby krapalmApril 29, 2025PR Newswire
